As prostate cancer cases continue to climb, Movember serves as a reminder for men to take command of their well-being and not ...
A man in his seventies developed fulminant capecitabine toxicity despite normal DPYD screening, revealing a rare variant that ...
The identification of 20 causal plasma proteins for prostate cancer represents a critical step toward addressing the need for improved diagnostic specificity and reveals promising new targets for ...
Scores of men’s lives in Sussex, Hampshire and Dorset are thought to have been saved thanks to a prostate health screening ...